Printer Friendly

Articles from M2 Pharma (September 2, 2015)

1-14 out of 14 article(s)
Title Author Type Words
Apricus Biosciences unveils Vitaros in Italy for treating erectile dysfunction. 201
Ardelyx regains control over research on NaP2b inhibitors. 184
Ascletis receives Taiwan approval to start Phase II clinical trial for all-oral interferon-free regimen to treat chronic hepatitis C. 245
Bristol-Myers Squibb receives rights to acquire Promedior and its fibrosis drug. 118
First Commercial US Patient Receives ReShape Medical's Integrated Dual Balloon System. 190
For US HHS Secretary Sebelius Named to Humacyte Board of Directors. 324
Illumina acquires GenoLogics. 138
Laccure develops Laccure Pessary for treatment and prevention of bacterial vaginosis. 137
Nektar awarded USD40m milestone payment for first commercial sale of MOVENTIG tablets in major European market. 230
Optilite Special Protein Analyser Launches in North America. 263
Pulmatrix Issued US Patent Covering Inhaled Dry Powder Technology. 357
Sanofi collaborates with Google's life sciences team. 136
Titan Spine to Expand Endoskeleton Implant Portfolio in Europe Via New Distribution Deal. 389
Zosano Pharma admits 20 healthy subjects in Phase 1 clinical study of Zolmitriptan for treating migraine headaches. 254

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters